Emulate, Inc. specializes in organs-on-chips technology designed to mimic human biology, enabling a better understanding of how diseases, medications, chemicals, and food impact human health. The company offers organ-chips that replicate the functions and disease states of various human organs, including the lung, intestine, liver, and skin. In addition to its organ-chips, Emulate provides software applications for drug development and research workflows, catering to a diverse clientele that includes biotechnology and pharmaceutical companies, consumer health and cosmetics industries, agricultural firms, and academic researchers. Founded in 2013 and based in Boston, Massachusetts, Emulate aims to set a new standard for accurately predicting human responses across multiple fields, including drug development and personalized medicine. The company was previously known as Emulate Living MicroDevices, Inc. before rebranding in 2014.